Liu Yang, Jiang Jun, Mo Minmin, Sun Xiaohong, Yu Kailong
The First Department of Orthopedics, Xinyu People's Hospital, 369 Xinxin Bei Road, Xinyu, 338000, Jiangxi, People's Republic of China.
The First Affiliated Hospital of Dalian Medical University, 222 Zhongshan Road, Xigang District, Dalian, Liaoning, 116011, People's Republic of China.
Clin Rheumatol. 2022 May;41(5):1313-1322. doi: 10.1007/s10067-021-06046-2. Epub 2022 Jan 10.
This study was conducted to investigate the prevalence of vertebral fracture (VF) and its risk in patients with rheumatoid arthritis (RA) as compared to healthy individuals, and to explore the underlying risk factors.
The electronic databases of PubMed, EMBASE, and the Cochrane Library were applied to search for the relevant literatures, which reported the prevalence of VF in both RA patients and healthy controls (up to Mar 31, 2021). The non-weighted prevalence of VF, pooled estimates of odds ratio (OR), and its 95% confidence intervals (CI) were calculated with the use of random-effects model; between-study heterogeneity was evaluated by Cochrane Q statistic, then was quantified with I. Publication bias was evaluated using Egger's linear regression test.
A number of 867 literatures were identified after searching for online databases, based on the inclusion and exclusion criteria, 11 eligible studies, which comprising 3805 RA patients and 59,517 healthy participants, were finally incorporated in meta-analysis. The results showed that RA patients had an increased prevalence of VF (20.29 vs 8.63%), and an elevated risk for VF (OR = 3.04, 95% CI 1.97-4.71) as compared to healthy population. Additional subgroup analysis suggested that age, body mass index (BMI), disease activity, and drug therapy might be associated with risk of VF in RA.
Overall, our study demonstrated an increased risk of VF in patients with RA, suggesting that age, race, BMI, disease activity, and drug therapy may be represented as risk factors contributing to the occurrence of VF in RA. Key Points • RA patients had the increased prevalence and risk of vertebral fracture (VF) as compared to healthy population. • Age, race, BMI, disease activity, and drug therapy might be associated with VF in RA. • Our findings would be helpful for the early evaluation of RA patients with high VF risk.
本研究旨在调查类风湿关节炎(RA)患者与健康个体相比椎体骨折(VF)的患病率及其风险,并探索潜在的风险因素。
应用PubMed、EMBASE和Cochrane图书馆的电子数据库检索相关文献,这些文献报道了RA患者和健康对照者中VF的患病率(截至2021年3月31日)。使用随机效应模型计算VF的非加权患病率、比值比(OR)的合并估计值及其95%置信区间(CI);通过Cochrane Q统计量评估研究间异质性,然后用I2进行量化。使用Egger线性回归检验评估发表偏倚。
在检索在线数据库后共识别出867篇文献,根据纳入和排除标准,最终纳入11项符合条件的研究,其中包括3805例RA患者和59517名健康参与者进行荟萃分析。结果显示,与健康人群相比,RA患者的VF患病率更高(20.29%对8.63%),VF风险也更高(OR = 3.04,95%CI 1.97 - 4.71)。进一步的亚组分析表明,年龄、体重指数(BMI)、疾病活动度和药物治疗可能与RA患者的VF风险相关。
总体而言,我们的研究表明RA患者发生VF的风险增加,提示年龄、种族、BMI、疾病活动度和药物治疗可能是导致RA患者发生VF的风险因素。要点 • 与健康人群相比,RA患者椎体骨折(VF)的患病率和风险增加。 • 年龄、种族、BMI、疾病活动度和药物治疗可能与RA患者的VF相关。 • 我们的研究结果有助于对VF高风险的RA患者进行早期评估。